Source: Annual Congress 2008 - Epigenetic modifications in lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
H. Slevogt (Berlin, Germany). Moraxella infection and histone deacetylase activity. Annual Congress 2008 - Epigenetic modifications in lung disease

Member's Comments

No comment yet.

Related content which might interest you: Decreased histone deacetylase activity in COPD Source: Annual Congress 2008 - Epigenetic modifications in lung disease Year: 2008 Histone deacetylase activity and gene expression in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 316s Year: 2001 Histone deacetylase activity is reduced in COPD. Modulation by theophylline Source: Eur Respir J 2003; 22: Suppl. 45, 4s Year: 2003 Histone acetylation and deacetylation: importance in inflammatory lung diseases Source: Eur Respir J 2005; 25: 552-563 Year: 2005 Steroids and histone deacetylase in ventilation-induced gene transcription Source: Eur Respir J 2007; 30: 865-877 Year: 2007 Histone deacetylases (HDACs) and lung disease Source: Annual Congress 2011 - Why is epigenetics important for lung disease? Year: 2011 IL-1β induced histone H3-K4 tri-methylation and RNA polymerase II recruitment to the SLPI gene Source: Eur Respir J 2005; 26: Suppl. 49, 556s Year: 2005 Investigation of the effect of histone deacetylase 2 function on Wegener‘s granulomatosis Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Effect of cigarette smoking on histone deacetylase activity in alveolar macrophages Source: Eur Respir J 2002; 20: Suppl. 38, 416s Year: 2002 The role of histone deacetylase 9 in the imbalance of Th17/Treg in bronchial asthma Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012 The effects of dexamethasone and IL-1β on histone H3 methylation in A549 cells Source: Eur Respir J 2003; 22: Suppl. 45, 224s Year: 2003 Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019 Global histone H3 lysine 4 (H3K4) dimethylation is an important prognostic factor in lung cancer Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Histone deacetylase inhibition significantly augments human mesothelioma cellular response to chemotherapeutic agents Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 Regulation of eosinophil and neutrophil apoptosis by histone hyperacetylation Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003 Re-education of tumor-associated macrophages by modulating histone deacetylases in lung cancer Source: ERS Lung Science Conference 2017 Year: 2017 I?B? glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES Source: Eur Respir J 2011; 38: 1444-1452 Year: 2011 Dexamethasone inhibits phosphorylation at histone H3 (Ser 10) Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004 LSC Abstract – Histone deacetylase 7 mediated metabolic remodeling: A new crosslink between pulmonary hypertension and cancer Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016